Skip to content
1st Counsel – Lifestyle
Author:
Ensysce Biosciences
Ensysce Biosciences CEO Presents at Inaugural Clinical Pain Symposium in Amsterdam
May 8, 2026
Ensysce Biosciences Secures IRB Approval of Final Phase of PF614-MPAR-102 Clinical Study
April 16, 2026
Ensysce Biosciences Secures Second Financing From 2025 Agreement to Advance Breakthrough Pain Programs
April 7, 2026
←
Previous Page
1
2